A61K31/10 - page 2 - CPC Classification Index

#301

20170007552

2017-01-12

Materials, methods and devices for altering cell reactivity

#302

20170000856

2017-01-05

Dietary supplements and formulations

#303

20160374978

2016-12-29

Antimicrobial compositions comprising glyceryl nitrates

#304

20160361286

2016-12-15

4-benzylsulfonyl-2-butenenitrile

#305

20160356773

2016-12-08

Methods and systems for modulating hormones and related methods, agents and compositions

#306

20160354442

2016-12-08

Therapeutic method of inducing mitochondrial biogenesis to treat skin and muscle pathologies

#307

20160317480

2016-11-03

Composition and Method of Pain Relief, Reduction of Inflammation, Maintenance of Joints, and Soothing Muscle Soreness

#308

20160310515

2016-10-27

Water-Dispersible Supplements and Methods

#309

20160296580

2016-10-13

Composition for improving lactation

#310

20160287535

2016-10-06

Uses and methods for the treatment of liver diseases or conditions

#311

20160271103

2016-09-22

Dietary supplement containing alkaline electrolyte buffers

#312

20160251307

2016-09-01

Aryl ethers and uses thereof

#313

20160250158

2016-09-01

Methods and compositions for the treatment of cancer

#314

20160235687

2016-08-18

Sugar ester nanoparticle stabilizers

#315

20160220684

2016-08-04

COMPOSITION AND METHOD FOR RELIEVING PAIN AND INFLAMMATION, TREATMENT OF ERECTILE DYSFUNCTION, AND TREATMENT OF ACNE

#316

20160193306

2016-07-07

Multi-supplement compositions

#317

20160158147

2016-06-09

Composition and method for orally administering one or more active agents to a pet

#318

20160151313

2016-06-02

Topical composition and delivery system and its use

#319

20160129018

2016-05-12

COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES

#320

20160106669

2016-04-21

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

#321

20160082073

2016-03-24

Pharmaceutical composition for treating a microbial infection

#322

20160067386

2016-03-10

Device and method to facilitate safe, adhesion-free surgical closures

#323

20160067317

2016-03-10

Methods of treating pulmonary sarcoidosis

#324

20160058779

2016-03-03

Methods for treating viral infections using hydrogen sulfide donors

#325

20160045466

2016-02-18

Treatment of pain with topical diclofenac

#326

20160038439

2016-02-11

Use of 7-a-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-estra-1,3,5(10)- triene-3,17B-diol and derivatives thereof

#327

20160030508

2016-02-04

Antiangiogenic small molecules and methods of use

#328

20160030476

2016-02-04

Compositions, Methods And Devices For Promoting Wound Healing And Reducing Infection

#329

20160008341

2016-01-14

Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations

#330

20160008303

2016-01-14

Use of 2,5-dihydroxybenzene derivatives for treating dermatitis

#331

20150374823

2015-12-31

Polyalkoxylated alcohols as excipients for pharmaceutical compositions

#332

20150366849

2015-12-24

Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations

#333

20150366844

2015-12-24

Composition comprising a TNFR agonist and at least one thioredoxin inhibitor for use in the treatment of carcinoma

#334

20150352045

2015-12-10

Skin enhancing beverage composition

#335

20150342969

2015-12-03

Methods for treating viral infections using hydrogen sulfide donors

#336

20150342848

2015-12-03

Antimicrobial compositions

#337

20150335663

2015-11-26

Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction

#338

20150328174

2015-11-19

Treatment of pain with topical diclofenac

#339

20150322004

2015-11-12

Method of treating advanced non-alcoholic steatohepatitis

#340

20150320707

2015-11-12

Treatment of pain with topical diclofenac

#341

20150313937

2015-11-05

Solution And Method For Treating Cancer

#342

20150313859

2015-11-05

Methods and compositions for treatment of cancer

#343

20150306073

2015-10-29

Thioredoxin protein inhibitors and uses thereof

#344

20150297540

2015-10-22

Uses and methods for the treatment of liver diseases or conditions

#345

20150297518

2015-10-22

Foamable formulation

#346

20150283156

2015-10-08

Compositions and formulations of glucosamine for transdermal and transmucosal administration

#347

20150265549

2015-09-24

Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone

#348

20150250896

2015-09-10

Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules

#349

20150238448

2015-08-27

FORMULATION OF RADIOPROTECTIVE ALPHA, BETA UNSATURATED ARYL SULFONES

#350

20150231098

2015-08-20

ANTISEPTIC, ANTISEBORRHEIC, EXFOLIATING COMPOSITION FOR GETTING RID OF OR PREVENTING ACNE

#351

20150196532

2015-07-16

Glycopyrrolate salts

#352

20150182492

2015-07-02

Ulcer treatment

#353

20150154345

2015-06-04

Reprogramming effector protein interactions to correct epigenetic defects in cancer

#354

20150150927

2015-06-04

Composition for improving lactation

#355

20150150902

2015-06-04

COMPOSITION AND METHOD FOR PROMOTING JOINT AND BONE HEALTH

#356

20150148393

2015-05-28

COSMETIC AND/OR PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATION AND RELATED SYNDROMES

#357

20150141476

2015-05-21

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea

#358

20150133507

2015-05-14

Pharmaceutical compositions comprising glitazones and Nrf2 activators

#359

20150125534

2015-05-07

IMATINIB SOLID DOSAGE FORMS RECONSTITUTED JUST BEFORE USE

#360

20150111850

2015-04-23

Composition for the treatment of inflammatory and immune disorders

#361

20150110809

2015-04-23

Modulators of exchange proteins directly activated by cAMP (EPACS)

#362

20150094381

2015-04-02

Use of propyl propane thiosulfinate and propyl propane thiosulfonate for the prevention and reduction of parasites in aquatic animals

#363

20150080348

2015-03-19

Compositions and methods for amelioration and prevention of drug-induced toxicity

#364

20150038468

2015-02-05

Estrogen antagonists as treatments for sclerosing disorders

#365

20150037320

2015-02-05

Treatment of macrophage-related disorders

#366

20150023922

2015-01-22

Methods for promoting neuronal development and/or health

#367

20150010638

2015-01-08

Method for improving water solubility of slightly soluble substance

#368

20140364387

2014-12-11

Methods and systems for modulating hormones and related methods, agents and compositions

#369

20140363420

2014-12-11

Method and composition for topical pain relief

#370

20140349375

2014-11-27

Use of methylsulfonylmethane (MSM) to modulate microbial activity

#371

20140348823

2014-11-27

Histone deacetylase (HDAC) inhibitors for the treatment of cancer

#372

20140341867

2014-11-20

TREATMENT OF STROKE USING ISOLATED PLACENTAL CELLS

#373

20140328823

2014-11-06

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#374

20140328778

2014-11-06

Use of 2,5-dihydroxybenzene derivatives for treating dermatitis

#375

20140323526

2014-10-30

Nutritional supplements

#376

20140315843

2014-10-23

TOPICAL PHARMACEUTICAL COMPOSITIONS OF THIOCOLCHICOSIDE AND METHYLSULFONYLMETHANE

#377

20140303212

2014-10-09

Method for treating neurodegeneration using a p38MAPK inhibitor

#378

20140242037

2014-08-28

APC-mediated tolerance induction for therapy of multiple sclerosis

#379

20140227272

2014-08-14

Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains

#380

20140221474

2014-08-07

Method and Formulation for Chemical Peeling

#381

20140212407

2014-07-31

TREATMENT OF OBESITY

#382

20140212373

2014-07-31

Multi-vinylsulfone containing molecule

#383

20140206654

2014-07-24

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

#384

20140205559

2014-07-24

Antifungal compositions for the treatment of skin and nails

#385

20140163105

2014-06-12

Topical preparation for pain relief

#386

20140148845

2014-05-29

Device and method to facilitate safe, adhesion-free surgical closures

#387

20140147866

2014-05-29

Method of screening of therapeutic agents for K-Ras mutant driven cancers

#388

20140134261

2014-05-15

Pharmaceutical Compositions Comprising Capsaicin Esters for Treating Pain and Cold Sores

#389

20140127328

2014-05-08

Methods and compositions for treating anxiety disorders or symptoms thereof

#390

20140079812

2014-03-20

Disulfide chemotherapeutic agents and methods of use thereof

#391

20140065224

2014-03-06

Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations

#392

20140051662

2014-02-20

TREATMENT OF MULTIPLE MYELOMA WITH MASITINIB

#393

20140050804

2014-02-20

COLD INFUSION PROCESS FOR FORTIFYING CORN AND/OR SOYBEANS

#394

20140045889

2014-02-13

Combination Drug Containing Probucol and a Tetrazolyalkoxy-Dihydrocarbostyril Derivative With Superoxide Supressant Effects

#395

20140038921

2014-02-06

Low side effect pharmaceutical composition containing antituberculosis drugs

#396

20140031312

2014-01-30

Compositions and formulations of glucosamine for transdermal and transmucosal administration

#397

20140023729

2014-01-23

Nutritional supplement for disinhibiting therapy of psychiatric patients

#398

20130345187

2013-12-26

Method for pre-screening and correlation of underlying SCARB1 gene variation to infertility in women and therapeutic use of progestational and other medications in treatment

#399

20130338225

2013-12-19

Compounds as L-cystine crystallization inhibitors and uses thereof

#400

20130338130

2013-12-19

METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS

#401

20130338117

2013-12-19

Therapeutic compounds for blocking DNA synthesis of POX viruses

#402

20130330373

2013-12-12

Cream composition enhancing skin absorption of glucosamine

#403

20130309325

2013-11-21

COMPOSITION AND METHOD FOR PROMOTING JOINT AND BONE HEALTH

#404

20130302412

2013-11-14

Transfer Factor Compositions

#405

20130281401

2013-10-24

COMBINATION THERAPY FOR THE TREATMENT OF DEPRESSION AND OTHER NON-INFECTIOUS DISEASES

#406

20130253069

2013-09-26

Use of DMSO for Destroying Adipocytes and Eliminating Cellulite and Adiposities

#407

20130243886

2013-09-19

Pharmaceutical composition and method of treating a microbial infection with sulcotidil

#408

20130243701

2013-09-19

Foamable formulation

#409

20130237611

2013-09-12

AQUEOUS FORMULATIONS OF (2-HYDROXYMETHYL-INDANYL-4-OXY)-PHENYL-4,4,4-TRIFLUOROBUTANE-1-SULFONATE

#410

20130203793

2013-08-08

Protection and treatment against influenza infection

#411

20130190355

2013-07-25

Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I

#412

20130165515

2013-06-27

Organosulfur compounds for the prevention and treatment of neurodegenerative diseases

#413

20130156797

2013-06-20

Method for preserving alum adjuvants and alum-adjuvanted vaccines

#414

20130131021

2013-05-23

Analogues of cilostazol

#415

20130123326

2013-05-16

ALLOSTERIC BINDING COMPOUNDS

#416

20130123293

2013-05-16

Opioid-containing oral pharmaceutical compositions and methods

#417

20130108586

2013-05-02

COMPOSITION AND METHOD OF DELIVERY OF L-ARABINOSE AND SELECT COMPOUNDS

#418

20130096489

2013-04-18

High shear application in medical therapy

#419

20130065967

2013-03-14

USE OF METHYLSULFONYLMETHANE (MSM) TO INHIBIT MICROBIAL ACTIVITY

#420

20130065870

2013-03-14

Treatment of pain with topical diclofenac

#421

20130065823

2013-03-14

Supplement for Strengthening the Muscles of a Human

#422

20130059915

2013-03-07

Treatment of pain with topical diclofenac

#423

20130045941

2013-02-21

Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases

#424

20130041034

2013-02-14

Treatment of pain with topical diclofenac compounds

#425

20130039977

2013-02-14

PHARMACEUTICAL COMPOSITION, A METHOD OF PREPARING IT AND A METHOD OF TREATMENT BY USE THEREOF

#426

20130035397

2013-02-07

Anti-Viral Compounds

#427

20130018059

2013-01-17

DIMETHYL SULFOXIDE (DMSO) FORMULATIONS FOR TREATING AUTISM

#428

20130012589

2013-01-10

Stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone

#429

20130012588

2013-01-10

Compositions and methods for prevention and treatment of wounds

#430

20120329712

2012-12-27

Induction of differential stress resistance and uses thereof

#431

20120322770

2012-12-20

Therapeutic compounds for blocking DNA synthesis of pox viruses

#432

20120309833

2012-12-06

Bexarotene analogs

#433

20120276212

2012-11-01

COMPOSITION COMPRISING PLANT AND/OR FISH OILS AND NON-OXIDIZABLE FATTY ACID ENTITIES

#434

20120276087

2012-11-01

Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases

#435

20120264804

2012-10-18

T TYPE CALCIUM CHANNEL BLOCKERS AND THE TREATMENT OF DISEASES

#436

20120264726

2012-10-18

Methods of sensitizing drug resistant microorganisms using methylsulfonylmethane (MSM)

#437

20120263714

2012-10-18

SUBSTITUTED HALOPHENOXYBENZAMIDE DERIVATIVES

#438

20120245179

2012-09-27

Method Of Therapeutic Administration of DHE To Enable Rapid Relief Of Migraine While Minimizing Side Effect Profile

#439

20120237570

2012-09-20

Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications

#440

20120231031

2012-09-13

COMPOSITION FOR IMPROVING LACTATION

#441

20120220667

2012-08-30

USE OF METHYLSULFONYLMETHANE (MSM) TO INHIBIT MICROBIAL ACTIVITY

#442

20120207827

2012-08-16

Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis

#443

20120172435

2012-07-05

Methods for treating acute acoustic trauma

#444

20120149672

2012-06-14

Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms

#445

20120135971

2012-05-31

Estrogen antagonists as treatments for sclerosing disorders

#446

20120134929

2012-05-31

TREATMENT OF MACROPHAGE-RELATED DISORDERS

#447

20120129775

2012-05-24

Antiangiogenic small molecules and methods of use

#448

20120128783

2012-05-24

Compositions and methods for delivery of frozen particle adhesives

#449

20120121723

2012-05-17

Antimicrobial Compositions

#450

20120108522

2012-05-03

HDAC INHIBITORS AND HORMONE TARGETED DRUGS FOR THE TREATMENT OF CANCER

#451

20120101160

2012-04-26

Use of chemical chaperones to treat glaucoma caused by misfolded or misprocessed proteins

#452

20120095048

2012-04-19

ALLOSTERIC BINDING COMPOUNDS

#453

20120094965

2012-04-19

Method and Formulation for Chemical Peeling

#454

20120089178

2012-04-12

Device and method to facilitate safe, adhesion-free surgical closures

#455

20120087947

2012-04-12

Use of 2,5-dihydroxybenzene derivatives for treating dermatitis

#456

20120087904

2012-04-12

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#457

20120083493

2012-04-05

Small-molecule modulators of Trp-p8 activity

#458

20120077764

2012-03-29

Compositions and method for treating infection in cattle and swine

#459

20120058965

2012-03-08

Methods and systems for modulating hormones and related methods, agents and compositions

#460

20120020982

2012-01-26

Formulations and treatments for trichology

#461

20120015960

2012-01-19

CHEMICAL INHIBITOR OF P53-SNAIL BINDING AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCER DISEASE CONTAINING SAME AS ITS ACTIVE INGREDIENT

#462

20110319349

2011-12-29

Methods for Reducing Platelet Activation and for the Treatment of Thrombotic Events

#463

20110311528

2011-12-22

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis

#464

20110306675

2011-12-15

COMPOSITIONS AND METHODS FOR INHIBITING NF-KB MEDIATED TUMORIGENICITY AND ADHESION-DEPENDENT SURVIVAL OF CANCER CELLS

#465

20110275658

2011-11-10

Opioid-containing oral pharmaceutical compositions and methods

#466

20110263580

2011-10-27

METHOD FOR TREATING ALZHEIMER'S DISEASE AND RELATED CONDITIONS

#467

20110251208

2011-10-13

Phosphodiesterase type III (PDE III) inhibitors or CA-sensitizing agents for the treatment of hypertrophic cardiomyopathy

#468

20110250259

2011-10-13

Method of treating and preventing breast diseases and breast cancer with medicated formula

#469

20110250184

2011-10-13

METHODS FOR DETERMINING EFFICACY OF A THERAPEUTIC REGIMEN AGAINST DELETERIOUS EFFECTS OF CYTOTOXIC AGENTS IN HUMAN

#470

20110245285

2011-10-06

PROCESS FOR PREPARATION OF ROSUVASTATIN ACETONIDE CALCIUM

#471

20110237555

2011-09-29

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea

#472

20110224179

2011-09-15

Medicament and method of diagnosis for treating subclinical Cushing's syndrome

#473

20110212082

2011-09-01

METHOD FOR PRODUCING TABLET COMPRISING NATURAL ALLICIN

#474

20110207822

2011-08-25

COMPOSITIONS FOR CLEANING AND DISINFECTING NASAL TRACT AND SINUS CAVITY

#475

20110203583

2011-08-25

Methods for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors

#476

20110190400

2011-08-04

Compounds for treatment of malignant tumors

#477

20110190240

2011-08-04

Nuclear factor kappa B pathway inhibitor composition and use of same

#478

20110189311

2011-08-04

Highly Absorbable Drug Composition and Method of Producing the Same

#479

20110178072

2011-07-21

STEREOSPECIFICITY OF METHYLSULFINYL REDUCTION

#480

20110177173

2011-07-21

Compounds as L-cystine crystallization inhibitors and uses thereof

#481

20110172185

2011-07-14

Therapeutic drug for adult T-cell leukemia

#482

20110166228

2011-07-07

COMPOSITION

#483

20110166223

2011-07-07

METHODS OF INHIBITING FGFR3 SIGNALING

#484

20110160148

2011-06-30

Diverse lead compound autotaxin inhibitors

#485

20110159048

2011-06-30

Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications

#486

20110158983

2011-06-30

COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES

#487

20110152263

2011-06-23

COMPOSITION AND METHOD FOR INHIBITING NOROVIRUS INFECTION

#488

20110152231

2011-06-23

METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS

#489

20110152222

2011-06-23

Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain

#490

20110138888

2011-06-16

TREATMENT OF OBESITY

#491

20110136210

2011-06-09

Use of methylsulfonylmethane (MSM) to modulate microbial activity

#492

20110110886

2011-05-12

SMALL MOLECULE INHIBITORS OF AUTOTAXIN AND METHODS OF USE

#493

20110105623

2011-05-05

USE OF METHYLSULFONYLMETHANE (MSM) TO MODULATE MICROBIAL ACTIVITY

#494

20110086119

2011-04-14

Preparation for the relief of disease

#495

20110077194

2011-03-31

Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method

#496

20110065788

2011-03-17

AQUEOUS FORMULATIONS OF (2-HYDROXYMETHYL-INDANYL-4-OXY)-PHENYL-4,4,4-TRIFLUOROBUTANE-1-SULFONATE

#497

20110054037

2011-03-03

Bis-aromatic anticancer agents

#498

20110052568

2011-03-03

Tablet comprising natural allicin and method for producing the same

#499

20110034519

2011-02-10

Nutritional supplements

#500

20110028504

2011-02-03

Formulation of radioprotective alpha beta unsaturated aryl sulfones

#501

20110027384

2011-02-03

Photosensitising composition and its uses

#502

20110015158

2011-01-20

METALLOENZYME INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES

#503

20100331377

2010-12-30

Compositions and methods for wound care

#504

20100311756

2010-12-09

METHODS FOR DELAYING THE PROGRESSION OF AT LEAST ONE OF CARDIAC HYPERTROPHY, CARDIAC REMODELING OR LEFT VENTRICULAR FUNCTION OR THE ONSET OF HEART FAILURE IN SUBJECTS IN NEED OF TREATMENT THEREOF

#505

20100298412

2010-11-25

Disulfide chemotherapeutic agents and methods of use thereof

#506

20100292660

2010-11-18

DERMAL DELIVERY DEVICE WITH ULTRASONIC WELD

#507

20100285029

2010-11-11

Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies

#508

20100284940

2010-11-11

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

#509

20100267801

2010-10-21

Cyclohexyl sulphones for treatment of cancer

#510

20100267663

2010-10-21

A COMPOSITION FOR CICATRISATION PROCESSES IN THE TREATMENT OF HYPERTROPHIC SCARS AND FOR IMPROVING THE BIOMECHANICAL PROPERTIES OF THE CUTIS

#511

20100256243

2010-10-07

Dosing Regimen for the Treatment of Alzheimer's Disease With Sulfonyl Fluorides

#512

20100249079

2010-09-30

Analogues of cilostazol

#513

20100240755

2010-09-23

Therapeutic and cosmetic compositions for treatment of skin

#514

20100240634

2010-09-23

Fluorene compound and pharmaceutical use thereof

#515

20100240616

2010-09-23

NOVEL LIPID COMPOUNDS

#516

20100234379

2010-09-16

Dual modulation of endocannabinoid transport and fatty-acid amide hydrolase for treatment of excitotoxicity

#517

20100226968

2010-09-09

Topical agent for muscle treatment

#518

20100222406

2010-09-02

T Type Calcium Channel Blockers and the Treatment of Diseases

#519

20100216852

2010-08-26

Methods for screening antimicrobial and antiviral compounds and uses thereof

#520

20100209419

2010-08-19

Method and formulation for treating adverse biological conditions

#521

20100196329

2010-08-05

COMPOSITION FOR TREATING ISCHEMIC LIMB DISEASE COMPRISING STEM CELLS DERIVED FROM ADIPOSE TISSUE

#522

20100130555

2010-05-27

Compositions and methods for treating or preventing hypoxic or ischemic injury

#523

20100130450

2010-05-27

Methods of Treating Fungal Infections

#524

20100113614

2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#525

20100112102

2010-05-06

THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF BENIGH PROSTATE HYPERPLASIA, PROSTATITIS, IMPOTENCE, INFERTILITY AND PROSTATE CANCER AND A METHOD FOR THE USE THEREOF

#526

20100112093

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#527

20100111857

2010-05-06

Compositions and methods for surface abrasion with frozen particles

#528

20100111848

2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#529

20100111847

2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#530

20100111846

2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#531

20100111845

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#532

20100111841

2010-05-06

Compositions and methods for surface abrasion with frozen particles

#533

20100111836

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#534

20100111835

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#535

20100111834

2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#536

20100111833

2010-05-06

Compositions and methods for surface abrasion with frozen particles

#537

20100087546

2010-04-08

USE OF DIMETHYL SULFONE (MSM) TO REDUCE HOMOCYSTEINE LEVELS

#538

20100087526

2010-04-08

Inhibitors of polyisoprenylated methylated protein methyl esterase

#539

20100081664

2010-04-01

METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE

#540

20100081663

2010-04-01

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

#541

20100080843

2010-04-01

Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis

#542

20100063152

2010-03-11

Method and topical formulation for treating localized edema

#543

20100048713

2010-02-25

COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER

#544

20100048621

2010-02-25

MEDICAMENT FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#545

20100047351

2010-02-25

Treatment of stroke using isolated placental cells

#546

20100047349

2010-02-25

Stabilized solid preparation

#547

20100035992

2010-02-11

Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies

#548

20100035887

2010-02-11

Therapeutic compounds for blocking DNA synthesis of pox viruses

#549

20100028368

2010-02-04

Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof

#550

20100022636

2010-01-28

Compositions and Methods For Enhancing The Antioxidant Status of Animals

#551

20100016533

2010-01-21

Polymers of fluorinated monomers and hydrocarbon monomers

#552

20100009036

2010-01-14

COLD INFUSION PROCESS FOR FORTIFYING CORN AND/OR SOYBEANS

#553

20100004396

2010-01-07

Polymers of fluorinated monomers and hydrocarbon monomers

#554

20100003303

2010-01-07

Polymers of fluorinated monomers and hydrocarbon monomers

#555

20100003231

2010-01-07

Polymers of fluorinated monomers and hydrocarbon monomers

#556

20090317464

2009-12-24

METHODS AND COMPOSITIONS FOR PRODUCING ANTI-ANDROGENIC EFFECTS

#557

20090312279

2009-12-17

Antimicrobial compositions

#558

20090312273

2009-12-17

Compositions comprising dimethyl sulfoxide (DMSO)

#559

20090306219

2009-12-10

TOPICAL USE OF PLANT EXTRACT FOR SKIN DETOXIFICATION

#560

20090306058

2009-12-10

Sulphone Derivatives for Treatment of Cancer

#561

20090306049

2009-12-10

Treatment of Barrett's Esophagus

#562

20090304747

2009-12-10

USE OF DMSO AND BOTULINUM TOXIN THERAPY FOR URINARY INCONTINENCE AND RELATED DISORDERS

#563

20090297469

2009-12-03

Cyanoacrylate Monomer Formulation Containing Diiodomethyl-p-tolylsulfone and 2,4,4'-Trichloro-2'-Hydroxydiphenyl Ether

#564

20090247624

2009-10-01

FORMULATIONS OF RADIOPROTECTIVE ALPHA BETA UNSATURATED ARYL SULFONES

#565

20090247479

2009-10-01

Therapeutic Use of Methionine to Reduce the Toxicity of Aminoglycoside Antibiotics

#566

20090215775

2009-08-27

Sulphonamido-Substituted Cyclohexyl Sulphones for Treatment of Cancer

#567

20090203633

2009-08-13

Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof

#568

20090181344

2009-07-16

PHARMACEUTICAL COMPOUND TO PREVENT AND TREAT FOCAL TISSULAR LESIONS AND INFECTIONS, METHOD AND APPLICATORS

#569

20090176826

2009-07-09

Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects

#570

20090098213

2009-04-16

PAIN RELIEF AND SOOTHING CREAM AND METHOD FOR MAKING SAME

#571

20090092668

2009-04-09

ACETAMINOPHEN FORMULATION FOR JOINT PAIN RELIEF

#572

20090068263

2009-03-12

MULTIPLE UNIT COMPOSITIONS

#573

20090068190

2009-03-12

ANTI-PROLIFERATIVE COMBINATIONS

#574

20090048156

2009-02-19

HDAC inhibitors and hormone targeted drugs for the treatment of cancer

#575

20090036541

2009-02-05

Applicator and chemical combination for better topical anesthesia

#576

20080287451

2008-11-20

Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

#577

20080274120

2008-11-06

Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent

#578

20080262088

2008-10-23

METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES

#579

20080260871

2008-10-23

METHOD AND COMPOSITION FOR INFUSING HERBAL EXTRACTS AND PHARMACEUTICALS THROUGH THE SKIN

#580

20080255185

2008-10-16

Small-molecule modulators of TRP-P8 activity

#581

20080254140

2008-10-16

Combination Methods and Therapies for Treating Opthalmic Conditions with 13-Cis-Retinyl Derivatives

#582

20080249181

2008-10-09

Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxlyamine

#583

20080242638

2008-10-02

Induction of differential stress resistance and uses thereof

#584

20080206353

2008-08-28

Formulations And Treatments For Trichology

#585

20080200924

2008-08-21

METHODS FOR MINIMALLY INVASIVE, NON-PERMANENT OCCLUSION OF A UTERINE ARTERY

#586

20080194518

2008-08-14

Antimicrobial Compositions

#587

20080193459

2008-08-14

Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies

#588

20080181884

2008-07-31

Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies

#589

20080171093

2008-07-17

Methods, Compositions and Devices for Inducing Stasis in Cells, Tissues, Organs, and Organisms

#590

20080161252

2008-07-03

Composition and methods for the treatment of proliferative diseases

#591

20080131498

2008-06-05

PHARMACEUTICAL COMPOSITION, A METHOD OF PREPARING IT AND A METHOD OF TREATMENT BY USE THEREOF

#592

20080131407

2008-06-05

Differentiation of bone marrow cells into neuronal cells and uses therefor

#593

20080125486

2008-05-29

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

#594

20080114075

2008-05-15

Use of 2,5-Dihydroxybenzene Derivatives for Treating Dermatitis

#595

20080114063

2008-05-15

Use of 2,5-Dihydroxybenzene Derivatives for the Treatment of Tissue Reactive Diseases

#596

20080114060

2008-05-15

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#597

20080113948

2008-05-15

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis

#598

20080113947

2008-05-15

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea

#599

20080085329

2008-04-10

Methods, Compositions and Devices for Inducing Stasis in Cells, Tissues, Organs, and Organisms

#600

20080058421

2008-03-06

COMPOSITIONS FOR CLEANING AND DISINFECTING NASAL TRACT AND SINUS CAVITY